Monkeypox Virus (MPXV) Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method) CapitalBio

Features 

• High sensitivity: The LOD is as low as 300 copies/ml;

• Quick detection: The detection only takes 65 min;

• Convenient test: Pre-aliquoted lyphilized nanoparticles enable reactions as soon as samples have been added, saving labor and effort;

• Convenient storage and shipment: Lyophilization formulation ensuring high stability, allowing 2~8℃ shipment.

Test Method

The kit is designed based on PCR - fluorescent probe technology

Sample Types 

Skin lesion samples (swabs of rash surfaces and/or exudates) and throat swabs

Order Information

Background Information

Monkeypox is an emerging zoonotic disease caused by monkeypox virus (MPXV), a member of the Orthopoxvirus genus in the Poxviridae family; it is a DNA virus related to smallpox virus. The clinical presentation is similar to the smallpox. To date, the unequivocal confirmation of mpox infection is done through the use of direct and indirect diagnostic methods. In direct tests, the clinical specimen is investigated for the presence of the virus, viral nucleic acids, or antigens. For this purpose, nucleic acid amplification tests (NAATs) are most commonly applied to identify the DNA (deoxyribonucleic acid) sequences that comprise the genetic material of the virus. In contrast, indirect MPXV tests detect the patient immune response against the viral infection.